Anti-SLIK3/ SLITRK3 monoclonal antibody
Anti-SLIK3/ SLITRK3 antibody for FACS & in-vivo assay
Go to SLITRK3/SLITRK3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP1685-Ab-1/ GM-Tg-hg-MP1685-Ab-2 | Anti-Human SLITRK3 monoclonal antibody | Human |
GM-Tg-rg-MP1685-Ab-1/ GM-Tg-rg-MP1685-Ab-2 | Anti-Rat SLITRK3 monoclonal antibody | Rat |
GM-Tg-mg-MP1685-Ab-1/ GM-Tg-mg-MP1685-Ab-2 | Anti-Mouse SLITRK3 monoclonal antibody | Mouse |
GM-Tg-cynog-MP1685-Ab-1/ GM-Tg-cynog-MP1685-Ab-2 | Anti-Cynomolgus/ Rhesus macaque SLITRK3 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP1685-Ab-1/ GM-Tg-felg-MP1685-Ab-2 | Anti-Feline SLITRK3 monoclonal antibody | Feline |
GM-Tg-cang-MP1685-Ab-1/ GM-Tg-cang-MP1685-Ab-2 | Anti-Canine SLITRK3 monoclonal antibody | Canine |
GM-Tg-bovg-MP1685-Ab-1/ GM-Tg-bovg-MP1685-Ab-2 | Anti-Bovine SLITRK3 monoclonal antibody | Bovine |
GM-Tg-equg-MP1685-Ab-1/ GM-Tg-equg-MP1685-Ab-2 | Anti-Equine SLITRK3 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP1685-Ab-1/ GM-Tg-hg-MP1685-Ab-2; GM-Tg-rg-MP1685-Ab-1/ GM-Tg-rg-MP1685-Ab-2; GM-Tg-mg-MP1685-Ab-1/ GM-Tg-mg-MP1685-Ab-2; GM-Tg-cynog-MP1685-Ab-1/ GM-Tg-cynog-MP1685-Ab-2; GM-Tg-felg-MP1685-Ab-1/ GM-Tg-felg-MP1685-Ab-2; GM-Tg-cang-MP1685-Ab-1/ GM-Tg-cang-MP1685-Ab-2; GM-Tg-bovg-MP1685-Ab-1/ GM-Tg-bovg-MP1685-Ab-2; GM-Tg-equg-MP1685-Ab-1/ GM-Tg-equg-MP1685-Ab-2 |
Products Name | Anti-SLITRK3 monoclonal antibody |
Format | mab |
Target Name | SLITRK3 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-SLITRK3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species SLIK3/ SLITRK3 VLP (virus-like particle) (Products Developing) |
Target information
Target ID | GM-MP1685 |
Target Name | SLITRK3 |
Gene ID | 22865,386750,310519,700660,608925,101091137,527364,100063273 |
Gene Symbol and Synonyms | SLITRK3,ST3 |
Uniprot Accession | O94933 |
Uniprot Entry Name | SLIK3_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000121871 |
Target Classification | N/A |
The target: SLITRK3, gene name: SLITRK3, also named as . This gene encodes a member of the Slitrk family of structurally related transmembrane proteins that are involved in controlling neurite outgrowth. The encoded protein contains two leucine-rich repeat (LRR) domains and a C-terminal domain that is partially similar to Trk neurotrophin receptor protein. Enhanced expression of this gene was found in tissue from several different types of tumors. Alternative splicing results in multiple transcript variants, all encoding the same protein. [provided by RefSeq, Jan 2016].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.